INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 285 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,577,000 | +160.8% | 380,000 | +79.5% | 4.67% | +739.7% |
| Q3 2021 | $7,890,000 | -56.2% | 211,670 | -52.0% | 0.56% | -61.8% |
| Q2 2021 | $17,997,000 | -13.9% | 440,889 | -28.4% | 1.46% | +106.7% |
| Q1 2021 | $20,901,000 | +49.7% | 615,989 | +40.3% | 0.70% | +14.5% |
| Q4 2020 | $13,960,000 | -7.9% | 438,989 | -25.7% | 0.62% | -43.9% |
| Q3 2020 | $15,165,000 | +26.6% | 590,989 | +26.7% | 1.10% | +15.1% |
| Q2 2020 | $11,975,000 | +212.9% | 466,502 | +87.3% | 0.95% | +230.9% |
| Q1 2020 | $3,827,000 | -90.6% | 249,002 | -79.1% | 0.29% | -95.7% |
| Q4 2019 | $40,870,000 | – | 1,191,200 | – | 6.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |